An FDA‐cleared focused ultrasound device (UltraShape, Syneron Candela®, Yokneam, Israel) for noninvasive abdominal fat reduction produces localized mechanical cellular membrane disruption in adipocytes. This study seeks to determine the safety… Click to show full abstract
An FDA‐cleared focused ultrasound device (UltraShape, Syneron Candela®, Yokneam, Israel) for noninvasive abdominal fat reduction produces localized mechanical cellular membrane disruption in adipocytes. This study seeks to determine the safety and efficacy of this device for use on the thighs.
               
Click one of the above tabs to view related content.